Yi‐Ju Chiang

The University of Texas MD Anderson Cancer Center

Papers

3

Total Citations

32

H-Index

3

About

Dr. Yi‐Ju Chiang is a surgical oncologist whose research focuses on optimizing oncologic outcomes in gastrointestinal and hepatobiliary cancers, with a particular emphasis on minimally invasive surgical techniques. Her major contributions include pioneering nationwide analyses of robotic and minimally invasive surgery for gastric and biliary tract cancers. In her landmark 2023 study on robotic gastrectomy for gastric cancer (12 citations), Dr. Chiang demonstrated significant improvements in short-term safety and oncological quality metrics across the United States, providing critical evidence for the adoption of robotic approaches. Her 2022 work on biliary tract cancer surgery (12 citations) revealed differential technical performance between open and minimally invasive approaches, highlighting the importance of achieving adequate lymphadenectomy and margin-negative resection. Additionally, Dr. Chiang’s 2023 investigation into postoperative opioid use after distal pancreatectomy (8 citations) established a concerning link between opioid consumption and increased rates of clinically significant pancreatic fistulas, offering actionable insights for perioperative pain management. Through these impactful studies, Dr. Chiang continues to shape evidence-based surgical practices, improving both the safety and oncological effectiveness of complex cancer surgeries.

Research Focus

Key Achievements

3
H-Index
3
Papers
32
Total Citations
11
Avg Citations/Paper
🏆 Most Cited Paper
Trends of Oncological Quality of Robotic Gastrectomy for Gastric Cancer in the United States
12 citations · 2023
📈 Most Prolific Year: 2023 (2 Papers)
🤝 Key Collaborators: 22
🏛 Institutions: The University of Texas MD Anderson Cancer Center

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago